>

Johnson Competition Analysis

<div class='circular--portrait' style='background:#FF6600;color: white;font-size:3em;padding-top: 40px;;'>JNJ</div>
JNJ -- USA Stock  

0.95 Dividend

Johnson Johnson competes with Allergan Plc, Astrazeneca PLC, Bristol Myers, GlaxoSmithKline PLC, and Johnson Johnson; as well as few others. The company runs under Healthcare sector within Drug Manufacturers?General industry. Analyzing Johnson Johnson competition can help investors to expand diversification possibilities for their existing portfolio and to get a better perspective on creating new portfolios. You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Johnson Johnson competition on your existing holdings. Please see Johnson Johnson Correlation with its peers.

Specify up to 10 symbols:


    
 Better Than Average     
    
 Worse Than Peers or Benchmark    View Performance Chart
JNJ
<div class='circular--portrait-small' style='background:#FF6600;color: white;font-size:1.1em;padding-top: 12px;;'>JNJ</div>
AGN
<div class='circular--portrait-small' style='background:#0D8ECF;color: white;font-size:1.6em;padding-top: 6px;;'>AL</div>
AZN
<div class='circular--portrait-small' style='background:#0D8ECF;color: white;font-size:1.6em;padding-top: 6px;;'>AS</div>
BMY
<div class='circular--portrait-small' style='background:#754DEB;color: white;font-size:1.1em;padding-top: 12px;;'>BMY</div>
GSK
<div class='circular--portrait-small' style='background:#FF6600;color: white;font-size:2.0em;padding-top:3px;;'>G</div>
LLY
<div class='circular--portrait-small' style='background:#754DEB;color: white;font-size:1.1em;padding-top: 12px;;'>ELI</div>
MRK
<div class='circular--portrait-small' style='background:#FF6600;color: white;font-size:1.1em;padding-top: 12px;;'>MRK</div>
NVS
<div class='circular--portrait-small' style='background:#2A0CD0;color: white;font-size:1.6em;padding-top: 6px;;'>NO</div>
PFE
<div class='circular--portrait-small' style='background:#FCD202;color: white;font-size:1.1em;padding-top: 12px;;'>PFE</div>
GILD
<div class='circular--portrait-small' style='background:#FCD202;color: white;font-size:1.1em;padding-top: 12px;;'>GIL</div>
 1.55 
 145.91 
Johnson Johnson
 2.58 
 198.17 
Allergan Plc
 0.042 
 47.59 
Astrazeneca PLC
 3.11 
 63.97 
Bristol Myers
 0.0477 
 41.92 
GlaxoSmithKline PLC
 3.46 
 138.15 
Eli Lilly
 1.74 
 81.33 
Merck
 3.41 
 90.08 
Novartis
 0.14 
 34.67 
Pfizer
 2.41 
 72.90 
Gilead Sciences
Market Volatility
(30 Days Market Risk)
Market Performance
(30 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(30 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance